[Heart failure: innovative understanding from traditional Chinese medicine (TCM) and treatment with classic TCM

Yu Lan1, Fu-Kun Luo1, Yue Yu1

  • 1Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.

Insights

Traditional Chinese Medicine (TCM) offers new insights into heart failure, a growing concern in China. TCM approaches address altered disease patterns and provide targeted herbal treatments to improve patient outcomes and reduce hospitalizations.

Area of Science:

  • Cardiology
  • Integrative Medicine
  • Traditional Chinese Medicine

Background:

  • Cardiovascular diseases, particularly heart failure, represent a significant public health burden in China, affecting approximately 8.9 million individuals.
  • Despite advancements in modern medicine, heart failure patients experience persistent challenges including recurrent dyspnea, diuretic resistance, and poor prognosis.
  • Traditional Chinese Medicine (TCM) categorizes heart failure as "heart water," recognizing altered etiologies and pathogeneses due to modern lifestyle, disease spectrum changes, and conventional drug use.

Purpose of the Study:

  • To investigate the evolving etiology and pathogenesis of heart failure within the framework of Traditional Chinese Medicine (TCM).
  • To identify and recommend specific TCM herbal formulas for various heart failure presentations and stages.
  • To propose a TCM-based approach for secondary prevention and improved clinical outcomes in heart failure patients.

Main Methods:

  • Analysis of modern heart failure presentations in relation to TCM principles, considering changes in disease spectrum, physical constitutions, and Western medication effects.
  • Identification of TCM etiological factors such as external pathogens, emotional stress, lifestyle, and organ deficiencies.
  • Categorization of TCM pathogeneses into acute (edema due to Yang deficiency, water retention with heat) and remission stages (Qi stagnation, various organ deficiencies, fluid retention, blood stasis).

Main Results:

  • TCM identifies diverse causes of heart failure, including infection, cardiac/psychological issues, and volume overload, aligning with modern medical observations.
  • Specific TCM herbal formulas are recommended for different pathogeneses: Zhenwu Decoction for Yang deficiency edema, Mufangji Decoction for heat-dampness, Chaihu Longgu Muli Decoction for liver Qi stagnation, Guizhi Decoction for heart Qi deficiency, Shenqi/Yougui Pills for kidney Yang deficiency, Yupingfeng Powder and others for Qi deficiency, Fangji Huangqi Decoction and others for fluid retention, and Guizhi Fuling Pills for blood stasis.
  • A treatment principle emphasizing integrated pathogenesis and pathology, along with TCM's concept of secondary prevention through tonifying formulas, is proposed.

Conclusions:

  • TCM offers a comprehensive framework for understanding and treating heart failure, acknowledging the impact of modern factors on disease presentation.
  • Tailored TCM herbal treatments can effectively address specific pathogeneses of heart failure, improving quality of life and reducing healthcare utilization.
  • Adopting TCM principles for secondary prevention can significantly ameliorate symptoms, reduce hospital admissions, and enhance overall clinical outcomes for heart failure patients.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
511
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314